Nowadays, we can observe a worldwide trend towards the development of synthetic biomaterials. Several studies have been conducted to better understand the cellular mechanisms involved in the processes of inflammation and bone healing related to living tissues. The aim of this study was to evaluate tissue behaviors of two different types of biomaterials: synthetic nano-hydroxyapatite/beta-tricalcium phosphate composite and bone xenograft in sub-critical bone defects in rat calvaria. Twenty-four rats underwent experimental surgery in which two 3 mm defects in each cavity were tested. Rats were divided into two groups: Group 1 used xenogen hydroxyapatite (Bio Oss™); Group 2 used synthetic nano-hydroxyapatite/beta-tricalcium phosphate (Blue Bone™). Sixty days after surgery, calvaria bone defects were filled with biomaterial, animals were euthanized, and tissues were stained with Masson’s trichrome and periodic acid–Schiff (PAS) techniques, immune-labeled with anti-TNF-α and anti-MMP-9, and electron microscopy analyses were also performed. Histomorphometric analysis indicated a greater presence of protein matrix in Group 2, in addition to higher levels of TNF-α and MMP-9. Ultrastructural analysis showed that biomaterial fibroblasts were associated with the tissue regeneration stage. Paired statistical data indicated that Blue Bone™ can improve bone formation/remodeling when compared to biomaterials of xenogenous origin.
3 December 2020 in Journal of Orthopaedic Research
The development of new bone substitutes has become an area of great interest in materials science. In fact, hydroxyapatite is the most commonly used biomaterial in defects that require bone reconstruction, and that is certainly why the discovery of new products with its formulation has been increasing continuously. The aim of this study was to analyze the biological behavior of a xenogeneic hydroxyapatite widely disclosed in the literature and a synthetic nano-hydroxyapatite/Beta tricalcium phosphate in critical defects in the calvaria of Wistar rats. For this, the groups were divided as follows: 24 adult male Wistar rats were used, weighing between 300 and 350 g, in three groups with eight animals each. In the CTRL group (control), only the clot was kept, without material insertion; in the Bioss group (bovine hydroxyapatite), Bio Oss®—Gleistlich® was introduced; and in the Blue Bone group (REG), the defect was filled in with synthetic nano-hydroxyapatite associated with betatriphosphate of calcium, Blue Bone®—Regener®. According to the results in Goldner’s Trichromics, we can observe a higher percentage of newly formed bone matrix in the REG group than in the CTRL and Bioss groups; in the VEGF, we had a more adequate cell modulation for blood vessel formation in the Blue Bone group (REG) compared to the Bioss and CTRL groups, while in osteopontin, a higher percentage of bone formation was observed in the Blue Bone group (REG) and Bioss group when compared to the CTRL group. We conclude that bone formation, mitosis-inducing cell modulation and main osteoblast activity were higher in the Blue Bone group (REG) than in the CTRL and Bioss groups.
Collagen membranes for tissue regeneration have been widely used in medicine and dentistry. Collagen membranes have a high biocompatibility and adequate healing time. The objective of the present work was to develop the combination of the use of type 1 collagen membranes in association with synthetic nanohydroxyapatite grafts. This study used 32 adult male Wistar rats weighing 250 g at 12 weeks of age. Critical defects of 8 mm were made in the temporoparietal region. The rats were divided into 5 groups of 8 rats each: sham group (only bone defects were made without being filled with biomaterial); Bio-Oss Group - the defect was filled with xenogeneic hydroxyapatite (Bio-Oss® - Geistlich); Bio-Oss + Membrane - the defect was filled with xenogeneic hydroxyapatite (Bio-Oss® - Geistlich) associated with collagen membrane (Mucrograft® – Geistlich); Blue-Bone® Group – the defect was filled with synthetic hydroxyapatite (Blue-Bone® – Regener); and Blue-Bone® + Green® Membrane Group – the defect was filled with synthetic hydroxyapatite (Blue-Bone® – Regener) associated with the type 1 collagen membrane (Green® Membrane Perio - Regener). The immunohistomic analysis showed that type 1 collagen membrane did not have contaminants. The ultrastructure analysis showed the type 1 collagen membrane has thin collagen fibers. The histology results showed it was possible through Goldner's Trichrome to measure the amount of collagen in each group analyzed. In conclusion, the type 1 collagen membrane, called Green Membrane Perio, has fibers organically organized, can be indicated for tissue regeneration, and the application is considered safe and biocompatible.
In medicine and dentistry, bone-loss treatment often uses hydroxyapatite combined with collagen membranes. The biocompatibility of these biomaterials depends on their composition and physical/mechanical properties. In this study, a graft composed of synthetic hydroxyapatite nanoparticle (Blue Bone®) and a bovine type I collagen membrane (Green Membrane Perio®) was developed compared with commercial Bio-Oss® graft and Mucograft® membrane. The materials were characterized by roughness, wettability, tensile testing, DSC, SEM, and TEM. In vivo, temporoparietal bone defects were created in 40 Wistar rats divided into five groups (n = 8): sham (no biomaterial); Bio-Oss®; Bio-Oss® + Mucograft®; Blue-Bone®; and Blue-Bone® + Green Membrane Perio®. Immunohistochemistry showed Green Membrane Perio® was made of thin, well-organized type I collagen fibers and was free of contaminants. Immunohistochemistry, histology, and immunohistochemical analyses indicated that Blue Bone® and Green Membrane Perio® were biocompatible and supported tissue regeneration. The Blue Bone® groups demonstrated higher collagen content than the Bio-Oss® + Mucograft® group. Quantitative and qualitative outcomes included morphological, thermal, mechanical, and surface property measurements, as well as cellular compatibility testing. The results showed comparable wettability and surface roughness, adequate membrane tensile strength, osteoconductive nanoparticle morphology, no adverse inflammatory reactions, and similar new bone formation metrics compared with controls. In conclusion, the combination of synthetic hydroxyapatite nanoparticles (Blue Bone®) and a bovine type I collagen membrane (Green Membrane Perio®) showed good performance when compared to established products and was considered safe and biocompatible for bone repair applications.